Spectranetics to collaborate on combining imaging technology with laser devices

By E. Janene Geiss

Philadelphia, May 18 - Spectranetics Corp. announced Thursday that it has entered into a research collaboration with BioScan Technologies Ltd., a privately held Israeli company.

The initial phase of the contract will focus on the feasibility of combining Spectranetics' fiber-optic laser catheters with the optical imaging technology of BioScan. If feasibility is proven, the project will move to a product development phase, according to a company news release.

"The incorporation of visualization capability into our devices would represent a significant technology advancement and have potential application with our atherectomy products, particularly for the treatment of chronic total occlusions, and our lead removal products," John G. Schulte, Spectranetics' president and chief executive officer, said in the release.

Spectranetics is a Colorado Springs, Colo., medical device company that makes single-use devices used in surgical procedures within the cardiovascular system in conjunction with its proprietary excimer laser system.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.